Positive Topline Results for Novartis' Leqvio® in Lowering LDL-C in Low-to-Moderate ASCVD Risk Patients
Aug 28, 2024
Clinical Invest Information
Athira Pharma Announces Key Milestones with Upcoming Presentation of LIFT-AD Clinical Trial Results for Alzheimer's Treatment
Aug 2, 2024
Clinical Study Validates ClarityDX Prostate's Efficacy in Predicting Prostate Cancer Risk
Jun 27, 2024
argenx Unfolds its Long-term Plan 'Vision 2030' to Bring Breakthrough Science to Thousands of Patients
Jun 18, 2024
Novartis Phase III Trial Shows Atrasentan Promising for IgA Nephropathy Treatment
May 26, 2024
Immix Biopharma Receives EU Orphan Drug Designation for NXC-201 in Multiple Myeloma
Apr 29, 2024
Athira Pharma Unveils Encouraging Clinical and Preclinical Results for Fosgonimeton at the AD/PD™ 2024 Conference
Mar 9, 2024
SciSparc Advances Autism Spectrum Disorder Treatment with SCI-210 Clinical Trial Progression
Mar 1, 2024
Projected Growth in Global Clinical Trials Outsourcing Market to Hit USD 74.38 Billion by 2031
Jan 16, 2024
MindMed's Strategic Shift in 2024: Focusing on Anxiety Treatments and Halting LSD Microdosing for ADHD
Jan 11, 2024
Setback for Mirum Pharmaceuticals as Livmarli Fails in Mid-Stage Study for Biliary Atresia
Dec 20, 2023
Vigil Neuroscience (VIGL) Shares Dip Following Interim Clinical Trial Data
Nov 18, 2023
Aeglea BioTherapeutics AGLE Receives Sell Rating Amid Market Dynamics
Nov 13, 2023
GH Research Advances Clinical Trials for GH001 in the Fight Against Treatment-Resistant Depression
Nov 9, 2023
GH Research Announces Clinical Progress and Path Forward for GH001 in the Battle Against Treatment-Resistant Depression
Nov 9, 2023
GH Research Advances Clinical Development for GH001 in Treatment-Resistant Depression
Nov 9, 2023